G Greer, R J Strassman. Show Affiliations »
Abstract
Mesh: See more » 3,4-Methylenedioxyamphetamine/adverse effects3,4-Methylenedioxyamphetamine/analogs & derivatives3,4-Methylenedioxyamphetamine/pharmacology3,4-Methylenedioxyamphetamine/therapeutic useAmphetamines/pharmacologyDrug and Narcotic Control/legislation & jurisprudenceHallucinogensHumansN-Methyl-3,4-methylenedioxyamphetaminePsychotherapyUnited States
Substances: See more » AmphetaminesHallucinogens3,4-MethylenedioxyamphetamineN-Methyl-3,4-methylenedioxyamphetamine
Year: 1985 PMID: 2865906 DOI: 10.1176/ajp.142.11.aj142111391
Source DB: PubMed Journal: Am J Psychiatry ISSN: 0002-953X Impact factor: 18.112